Short-Term Risk for Below-Knee Amputation Not Increased With SGLT2i
Risk for below-knee amputation not increased versus DPP-4 inhibitor use in patients with type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.